MEDERA's SARDOCOR ANNOUNCES FDA CLEARANCE OF IND FOR FIRST-IN-HUMAN GENE THERAPY CLINICAL TRIAL FOR DMD CARDIOMYOPATHY

  • Roger Hajjar,

Press/Media

Period1 Dec 2022

Media coverage

1

Media coverage

  • TitleMEDERA's SARDOCOR ANNOUNCES FDA CLEARANCE OF IND FOR FIRST-IN-HUMAN GENE THERAPY CLINICAL TRIAL FOR DMD CARDIOMYOPATHY
    Media name/outletMENAFN -Press Releases (English)
    Country/TerritoryJordan
    Date1/12/22
    PersonsRoger Hajjar,
View all 1
View less